EP3606504
STÖÐUG MÓTEFNISSAMSETNING
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.3.2018EP published:
19.7.2023EP application number:
18719338.8
EP translation filed:
16.8.2023Grant published:
15.10.2023EPO information:
European Patent Register
Max expiry date:
22.3.2038Expiry date:
22.3.2027Next due date:
31.3.2027
Title in English:
STABLE ANTIBODY FORMULATIONLanguage of the patent:
English
Timeline
Today
23.3.2018EP application
19.7.2023EP Publication
16.8.2023Translation submitted
15.10.2023Registration published
22.3.2027Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
Inventor
Name:
HU, QingyanAddress:
Tarrytown, New York 10591, US
Name:
LIU, DingjiangAddress:
Tarrytown, New York 10591, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201762482270 PDate:
6.4.2017Country:
US
Classification
Categories:
A61K 9/00, A61K 39/00, A61K 47/18, A61K 47/26, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 6.3.2024
Expires: 22.3.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 12.3.2025
Expires: 22.3.2026
Payer: Árnason Faktor ehf.
Number: 9
Paid: 20.3.2026
Expires: 22.3.2027
Payer: Árnason Faktor ehf.